Ipsen: extension of the deadline for its tender offer for Albireo Pharma
As a reminder, the tender offer offers a net price of $42 per share, payable to the holder in cash, without interest and after applicable withholding taxes, plus one non-transferable contractual guaranteed value certificate (GVC) per share.
As of 6:00 pm Eastern Time on February 21, approximately 13,229,445 Albireo Pharma shares had been validly tendered to the tender offer and not validly withdrawn, representing approximately 63% of the shares outstanding as of January 20.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction